70% of human blood ready for transfusion was found to contain Xanax. This is an insight into the country's Xanax habit. Do you want to learn how to wean off Xanax properly? We know how terrifying it is to realize you are dependent on Xanax and how hard it may be to believe you can Wean Off Xanax. We know most gave tried to Get Off Xanax only to reinstate. We know because our team has been on benzodiazepines, regained our lives and are now helping others to also Get Off Xanax properly. We have used a powerful but holistic approach to Tapering Off Xanax for 15 years, reaching 78 countries and every state of the U.S. We know how to ease Xanax Withdrawal Symptoms so you can Wean Off Xanax more comfortably. Too many herbs, over-the-counter items and even Vitamins can increase Xanax Withdrawal Symptoms, so we use specialized, calming and sleep promoting nutraceuticals that will not interact but help you to Wean Off Xanax and Stay Off Xanax. Please do not attempt to Taper Off Xanax without professional assistance, Contact our nonprofit today.
SUCCESSFUL CHOICES YOU CAN MAKE RIGHT NOW
REACH OUT FORM
Our Xanax weaning program is a slow taper that allows you to safely Get Off Xanax under the guidance of Our Team, Your Physician and Pharmacist. The Pre-Taper is for Symptom Relief. You will not wean Xanax until you feel better. This is where our Advanced Nutraceuticals are critical. Point of Return provides healthy, Drug-Free Strategies to help ease Xanax withdrawal and support well-being*
Our areas of expertise are Antidepressants, Benzodiazepines, Sleeping Pills and Painkillers on a case-by-case basis. Our In-Home programs are individualized based on your situation. An assessment is done once you start the Xanax Withdrawal Program which allows us to individualize your gameplan based on age; length of time on the medications; health challenges; lifestyle, stress levels; additional medications; and interactions. Don't Wean Xanax alone, work with our Prescription Drug Experts.
Imagine being Free of Xanax Dependency
- Proven Program completed In-Home with Expert Guidance
- Slowly Wean Off Xanax
- All-Natural Nutraceuticals to help Ease Xanax Withdrawal
- Professional information on interactions
- Free Mentoring on our 24/7 private Discussion Board
- Free Assessment Upon Starting our Program (a $400 value)
XANAX WITHDRAWAL SUCCESS STORIES
"Me, my husband and my 2 children are so grateful! You saved me and I'm forever grateful for the work you put into this so people like me can have a quality of life during the taper and off the drug! I just can't thank you enough!" More...
Gretchen (Xanax Withdrawal Success Story)
"I just wanted to let you know that I'm doing well - thanks to your program. I don't think I could have ever done it alone. Please thank everyone in the office for me. I am deeply grateful to you all." More...
Diane (Xanax Withdrawal Success Story)
"Between my faith in God and the help of Point of Return, I have been Ambien and Xanax free!" More...
Jeff (Xanax Withdrawal Success Story)
"It has been one year this month since I began the program and today I am free of drugs. Free from Xanax which was causing me more anxiety." More...
Laura (Xanax Withdrawal Success Story)
"I do know that I would not be where I am today if it had not been for Point of Return. Good luck on your path back to happiness. I will never take life and people for granted again." More...
Janet (Xanax Withdrawal Success Story)
"You have given me that hope. It is tangible, it is reachable. Each day proves that and with that a new, better life emerges. I am returning to health!" More...
Kathy (Xanax Withdrawal Success Story)
Point of Return was with me every step of the way shedding light on such a dark period of my life. Point of Return isn't just a program, it's a lifestyle. More...
—Jessica (Xanax Withdrawal Success Story)
EXPERIENCE and TEAMWORK
using a Natural Approach
Xanax History and Information
Xanax (Alprazolam) was first released 1976 and became a blockbuster drug in the United States. Xanax has a fast onset of action with 90% of the peak effect achieved within the first hour. The time-released formation reaches full peak effect in approximately 1-1/2 hours. This short action also contributes to issues of tolerance, where the calming effect diminishes within shorter periods of time. For some, tolerance can occur within a couple of days, necessitating a dosage increase. Rapid withdrawal of Xanax can lead to the under activity of GABA which in turn causes the nervous system to become hyper-excited. Xanax is considered to be more toxic and have a higher overdose risk than other benzodiazepines, leading to more emergency room visits than other benzodiazepines. Insomnia and extreme anxiety are common during a rapid Xanax Withdrawal. An abrupt or rapid withdrawal can be life-threatening due to the seizure and high blood pressure risk. Xanax must be tapered slowly to minimize withdrawal symptoms.
In the late 1960s Xanax was created to be a sleep aid with muscle relaxant qualities, but when Dr. David Sheehan became involved Upjohn Pharmaceuticals presented the initial Xanax drug application to the FDA as an antidepressant to compete against Tricyclic Antidepressants, stating that Xanax was a safer and less toxic drug. The FDA initially approved the application, then changed their minds and told Upjohn they had to release Xanax as an anti-anxiety medication versus an antidepressant. Xanax was released in 1981and within two years became a blockbuster drug.
Pfizer Pharmaceutical entered the list of the largest mergers after increasing its global market share to 11% when Xanax was brought into their portfolio. Xanax is the number one prescribed psychiatric medication in the United States and between 2004 and 2008 there was an 89% increase in emergency room visits due to Xanax addiction. Michael Jackson was consuming between 30-40 Xanax a day prior to his death.
Xanax has a fast onset of action, reaching peak blood levels in 1.5 hours. Xanax is metabolized very rapidly versus other benzodiazepines therefore its effects are felt but also diminish quickly. This short half-life causes a rapid onset of tolerance, where the body calls for higher doses of the drug in an attempt to achieve a calm state.
Xanax should only be prescribed for very short periods of time (7-10 consecutive days) and yet too many are given Xanax for months or years. Xanax use and abuse has reached epidemic proportions among college students and recently the University of Alabama implemented a no-drug policy that includes testing for Xanax.
Xanax Withdrawal Symptoms, Side Effects, Adverse Reactions
XANAX WITHDRAWAL SYMPTOMS MAY INCLUDE:
aggression, anxiety, balance issues , blurred vision, brain zaps, concentration impairment, constipation, crying spells, depersonalization, diarrhea, dizziness. electric shock sensations, fatigue, flatulence, flu-like symptoms, hallucinations, hostility, highly emotional, indigestion, irritability, impaired speech, insomnia, jumpy nerves, lack of coordination, lethargy, migraine headaches / increased headaches, nausea, nervousness, over-reacting to situations, paranoia, repetitive thoughts or songs, sensory & sleep disturbances, severe internal restlessness (akathisia), stomach cramps, tremors, tinnitus (ear ringing or buzzing), tingling sensations, troubling thoughts, visual hallucinations / illusions, vivid dreams, speech or visual changes, worsened depression, insomnia, abdominal and muscle cramps, convulsions, feeling of discomfort, inability to fall asleep or stay asleep, sweating, tremors, vomiting
XANAX SIDE EFFECTS MAY INCLUDE:
daytime drowsiness, amnesia or forgetfulness, memory impairment, muscle weakness, lack of balance or coordination, numbness, burning, pain, or tingly feeling, headache, blurred vision, depressed mood, feeling nervous, excited or irritable, Nausea, vomiting, stomach discomfort, dry mouth, increased thirst, confusion, feeling restless, low energy, feeling weak, cognitive dysfunction, constipation, depression, fatigue, tremor, weigh gain or loss, anxiety, vision issues / blurred vision, ataxia, menstral issues, nervousness ,rash
XANAX ADVERSE REACTIONS MAY INCLUDE: per PDR
Severe: seizures, angiodema, Stevens-Johnson syndrome, Hepatic failure, teratogenesis
Moderate: withdrawal, memory impairment, impaired cognition, constipation, dysarthria, sinus tachycardia, depression, confusion, ataxia , edema, hypotension, akathisia, dyskinesia, hot flashes, amnesia, euphoria, mania, impulse control symptoms, dysphonia, hypotonia, urinary incontinence, dysuria, photophobia, dyspnea, hallucinations, blurred vision, palpitations, chest pain, tolerance, psychological dependence, physiological dependence, hostility, peripheral edema, jaundice, hyperbilirubinemia, elevated hepatic enzymes, hyperprolactinemia,hepatitis, galactorrhea
Mild: drowsiness, fatigue, appetite stimulation, dizziness, weight gain, weight loss, nausea, anxiety, xerostomia, libido decrease, menstrual irregularity, libido increase, hypersalivation, infection, syncope, dysmenorrhea, paresthesias, arthralgia, influenza, abnormal dreams, lethargy, myalgia, anorexia, pruritus, psychomotor impairment, asthenia, tinnitus, epistaxis, rhinorrhea, rash, mydriasis, urticaria, fever, agitation, nightmares, irritability, tremor, malaise, back pain, vertigo, muscle cramps, insomnia, weakness, headache, hyperventilation, diaphoresis, nasal congestion, rhinitis, diarrhea, dyspepsia, abdominal pain, vomiting, diplopia, gynecomastia
Abrupt discontinuation, benzodiazepine dependence, seizure disorder, seizures, status epilepticus, substance abuse
Alprazolam can cause physical and psychological dependence, and should be used with caution in patients with known, suspected, or a history of substance abuse. The risk of dependence with alprazolam appears to be most probable with daily dosages greater than 4 mg and with a treatment period of more than 12 weeks. Abrupt discontinuation of alprazolam after prolonged use should be avoided. Abrupt discontinuation of benzodiazepine therapy has been reported to cause a withdrawal syndrome (see Adverse Effects), especially following high dose or prolonged benzodiazepine therapy. However, benzodiazepine dependence can occur with therapeutic doses administered for as few as 1—2 weeks and withdrawal symptoms may be seen following the discontinuance of therapy. Benzodiazepine withdrawal also can be more intense if the benzodiazepine involved possesses a relatively short duration of action such as alprazolam. Panic rebound may be particularly problematic for patients receiving higher doses for panic disorder. Patients with a history of a seizure disorder or who are taking other drugs that lower the seizure threshold (i.e., TCAs, phenothiazines) should not be withdrawn abruptly from alprazolam due to the risk of precipitating seizures; status epilepticus has also been reported during therapy with immediate-release alprazolam. During withdrawal, the greatest risk of seizure appears to be during the first 24 to 72 hours. Seizures have also been reported with the use of the extended-release formulation of alprazolam, due to abrupt withdrawal and/or concomitant alcohol intake. Alprazolam (immediate-release or extended-release formulations) should be withdrawn slowly, using a gradual tapering schedule. Flumazenil, a benzodiazepine receptor antagonist, is indicated for partial or complete reversal of the depressive effects of benzodiazepines, and may be useful in overdose situations (see Flumazenil monograph). The prescriber should be aware of the risk for seizure activity with flumazenil use, particularly in long-term users of benzodiazepines or patients presenting with a cyclic antidepressant overdose. Anxiety
Worsening of daytime anxiety has been reported with the use of some hypnotic benzodiazepines, such as alprazolam, as few as 10 days after continuous use. In some patients this may be due to interdose withdrawal. If increased daytime anxiety is observed, it may be advisable to discontinue treatment gradually.
Xanax References and FDA Information
According to the FDA "Seizures attributable to XANAX were seen after drug discontinuance or dose reduction in 8 of 1980 patients with panic disorder or in patients participating in clinical trials where doses of XANAX greater than 4 mg/day for over 3 months were permitted. Five of these cases clearly occurred during abrupt dose reduction, or discontinuation from daily doses of 2 to 10 mg. Three cases occurred in situations where there was not a clear relationship to abrupt dose reduction or discontinuation. In one instance, seizure occurred after discontinuation from a single dose of 1 mg after tapering at a rate of 1 mg every 3 days from 6 mg daily. In two other instances, the relationship to taper is indeterminate; in both of these cases the patients had been receiving doses of 3 mg daily prior to seizure. The duration of use in the above 8 cases ranged from 4 to 22 weeks. There have been occasional voluntary reports of patients developing seizures while apparently tapering gradually from XANAX. The risk of seizure seems to be greatest 24-72 hours after discontinuation (see DOSAGE AND ADMINISTRATION for recommended tapering and discontinuation schedule)."
Withdrawal reactions may occur when dosage reduction occurs for any reason. This includes purposeful tapering, but also inadvertent reduction of dose (eg, the patient forgets, the patient is admitted to a hospital). Therefore, the dosage of XANAX should be reduced or discontinued gradually (see DOSAGE AND ADMINISTRATION)."
DOSAGE AND ADMINISTRATION PER THE FDA:
To discontinue treatment in patients taking XANAX, the dosage should be reduced slowly in keeping with good medical practice. It is suggested that the daily dosage of XANAX be decreased by no more than 0.5 mg every three days (see DOSAGE AND ADMINISTRATION). Some patients may benefit from an even slower dosage reduction. In a controlled postmarketing discontinuation study of panic disorder patients which compared this recommended taper schedule with a slower taper schedule, no difference was observed between the groups in the proportion of patients who tapered to zero dose; however, the slower schedule was associated with a reduction in symptoms associated with a withdrawal syndrome.
As with all benzodiazepines, paradoxical reactions such as stimulation, increased muscle spasticity, sleep disturbances, hallucinations and other adverse behavioral effects such as agitation, rage, irritability, and aggressive or hostile behavior have been reported rarely. In many of the spontaneous case reports of adverse behavioral effects, patients were receiving other CNS drugs concomitantly and/or were described as having underlying psychiatric conditions. Should any of the above events occur, alprazolam should be discontinued. Isolated published reports involving small numbers of patients have suggested that patients who have borderline personality disorder, a prior history of violent or aggressive behavior, or alcohol or substance abuse may be at risk for such events. Instances of irritability, hostility, and intrusive thoughts have been reported during discontinuation of alprazolam in patients with posttraumatic stress disorder.
*While great care has been taken in organizing and presenting the material throughout this website, please note that it is provided for informational purposes only and should not be taken as Medical Advice.
*The statements on this website have not been evaluated by the Food and Drug Administration (FDA). The products and labels mentioned / sold are not intended to diagnose, treat, cure, or prevent any disease or illness.
* Testimonial results may vary person to person.
*The program outlined in Point of Return is not meant to substitute your doctor, instead it is to be utilized With Your physician to help you with your drug withdrawal process and with his or her consent throughout.
*This program is not meant to cure or prevent any disease or illness.
*Because prescription medications can cause severe withdrawal reactions, do not stop taking any medication without first consulting your physician. The decision to taper any medication should be discussed with your doctor and done with their consent and support. More..